|
SPTLC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.960800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.798400E-03 |
| Normal-vs-Stage2 |
3.500100E-03 |
| Normal-vs-Stage3 |
3.971300E-04 |
| Normal-vs-Stage4 |
1.6318299999929E-05 |
| Stage1-vs-Stage2 |
1.607790E-01 |
| Stage1-vs-Stage3 |
9.484200E-02 |
| Stage1-vs-Stage4 |
8.521500E-03 |
| Stage2-vs-Stage3 |
8.437200E-01 |
| Stage2-vs-Stage4 |
3.753400E-01 |
| Stage3-vs-Stage4 |
1.793190E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.797000E-04 |
| Normal-vs-AfricanAmerican |
2.677700E-02 |
| Normal-vs-Asian |
1.830020E-02 |
| Caucasian-vs-AfricanAmerican |
8.660800E-01 |
| Caucasian-vs-Asian |
7.538000E-01 |
| AfricanAmerican-vs-Asian |
7.184800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.172500E-04 |
| Normal-vs-Female |
6.172200E-04 |
| Male-vs-Female |
5.562200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.412400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.679280E-03 |
| Normal-vs-Age(61-80Yrs) |
2.54690000001112E-06 |
| Normal-vs-Age(81-100Yrs) |
4.153900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.078200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.237190E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.435600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.334400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.448600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.729000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.808100E-02 |
| Classical-VS-Follicular |
2.455700E-03 |
| Classical-VS-Other |
3.638600E-01 |
| Classical-VS-Normal |
3.837500E-02 |
| Tall-VS-Follicular |
5.675600E-01 |
| Tall-VS-Other |
8.580000E-01 |
| Tall-VS-Normal |
1.635580E-03 |
| Follicular-VS-Other |
9.173600E-01 |
| Follicular-VS-Normal |
1.001670E-04 |
| Other-VS-Normal |
6.016400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.240400E-04 |
| Normal-vs-N1 |
1.004980E-04 |
| N0-vs-N1 |
2.436200E-01 |
|
|
